FDA Alert: Do Not Use Chloroquine Phosphate Intended for Fish as Treatment for COVID-19 in Humans

The FDA’s Center for Veterinary Medicine has recently become aware that some consumers may mistake chloroquine phosphate used to treat disease in aquarium fish for FDA-approved drugs (used to treat malaria and certain other conditions in humans) that are being studied as a COVID-19 treatment for humans. Unfortunately, we have learned that one person in the United States has died after he and his wife reportedly took chloroquine used to treat their fish in an attempt to prevent COVID-19; his wife also became very ill. We are continuing to investigate this incident.

[...]

Life-threatening counterfeit drugs taught Rick Roberts that medicine safety can’t be taken for granted

Rock Roberts opening the Senate briefing

Life-threatening counterfeit drugs taught Rick Roberts that medicine safety can’t be taken for granted. Safe medicines advocate Rick Roberts opening the Senate briefing, September 24, 2019. Rick Roberts, a professor at the University of San Francisco and a member of The Partnership for Safe Medicines’ Advisory Board, began thinking about the problem of medicine safety…

[...]

Executive Director of Colon Cancer Association Warns Against “Ill-Considered Drug Importation Scheme”

This editorial by Andrew Spiegel was published in The International Business Times on March 23, 2020. Mr. Spiegel is executive director of the Global Colon Cancer Association and Chair of the World Patient Alliance. President Trump, Price Controls Can’t Combat Coronavirus The U.S. outbreak of novel coronavirus, COVID-19, has quickly evolved into a national nightmare.…

[...]

DEA Warns that Counterfeit Pills and Fentanyl Continue to Threaten Americans

Each year, the U.S. Drug Enforcement Administration pools the knowledge of law enforcement agencies around the country to produce its National Drug Threat Assessment. This year, fentanyl, counterfeit prescription pills, and the pill presses are all listed as things that will continue to endanger American lives…

[...]

HHS comments come in overwhelmingly against Canadian drug importation proposal

Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.

[...]